Hypoglycemic events were rarely severe and infrequently resulted in a change to therapy (e.g., treatment interruption or dose change) or discontinuation of treatment
Studies and Research (PDF) Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury
In addition, it has been shown that SAG pretreatment significantly prevents CCl4-induced cytotoxicity, is protective in restoring mitochondrial autophagy, and attenuates fibrosis, collagen deposition, hepatocellular damage and organ dysfunction
Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers
doi: 10.1038/s41590-021-00962-w 241 SartoriusR.TrovatoM.MancoR.DApiceL.De BerardinisP
Many patients report feeling improvements in their mental ability, physical performance, and overall health almost immediately after a NAD IV therapy session